AAAAAA
Results: 1-25/26
Authors:
FREYER G
LIGNEAU B
TRILLETLENOIR V
Citation: G. Freyer et al., COLONY-STIMULATING FACTORS IN THE PREVENTION OF SOLID TUMORS INDUCED BY CHEMOTHERAPY IN PATIENTS WITH FEBRILE NEUTROPENIA, International journal of antimicrobial agents, 10(1), 1998, pp. 3-9
Authors:
VINCENT P
GUASTALLA JP
PIEDBOIS P
WEBER B
GANEM G
CURE H
TRILLETLENOIR V
GOUPIL A
MIGNOT L
PUJADELAURAINE E
Citation: P. Vincent et al., TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA), Annals of oncology, 9, 1998, pp. 323-323
Authors:
TRILLETLENOIR V
CUCHERAT M
GERARD JP
BOISSEL JP
Citation: V. Trilletlenoir et al., MAINTENANCE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER, Lung cancer, 21(3), 1998, pp. 221-223
Authors:
BOMPAS E
FREYER G
TRILLETLENOIR V
Citation: E. Bompas et al., MANAGEMENT OF NON REMOVABLE NON-SMALL-CEL L LUNG-CARCINOMA - RECOMMENDATIONS FROM THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY (ASCO), Bulletin du cancer, 85(2), 1998, pp. 125-127
Authors:
GILLY FN
SAYAGBEAUJARD AC
BIENVENU J
AYMARD M
TOURAINEMOULIN F
FAVROT M
TRILLETLENOIR V
PAVIRANI A
COURTNEY M
FRANCOIS Y
GLEHEN O
BANSSILLON V
VIGNAL J
ROSS M
Citation: Fn. Gilly et al., GENE-THERAPY WITH ADV-IL2 (TG-1021) IN UNRESECTABLE DIGESTIVE ADENOCARCINOMA - PHASE I-II STUDY, FIRST INCLUSIONS, Cancer gene therapy, 4(5), 1997, pp. 332-333
Authors:
LIGNEAU B
FREYER G
GIRAUD S
ISAAC S
BOMBARON P
ESPINOUSE D
PLAUCHU H
FISCHER G
GERARD JP
LENOIR G
TRILLETLENOIR V
Citation: B. Ligneau et al., NEUROSARCOMA IN A PATIENT WITH TYPE-1 NEU ROFIBROMATOSIS, La Presse medicale, 26(10), 1997, pp. 458-463
Authors:
FREYER G
LIGNEAU B
TRANCHAND B
ARDIET C
SERREDEBEAUVAIS F
TRILLETLENOIR V
Citation: G. Freyer et al., PHARMACOKINETIC STUDIES IN CANCER-CHEMOTHERAPY - USEFULNESS IN CLINICAL-PRACTICE, Cancer treatment reviews, 23(3), 1997, pp. 153-169
Authors:
TRILLETLENOIR V
FREYER G
Citation: V. Trilletlenoir et G. Freyer, CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST-CANCER AND COLORECTAL-CANCER - RECOMMENDATIONS OF THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY (ASCO), Bulletin du cancer, 84(7), 1997, pp. 767-768
Authors:
COTTO C
BERILLE J
SOUQUET PJ
RIOU R
CROISILE B
TURJMAN F
GIROUX B
BRUNE J
TRILLETLENOIR V
Citation: C. Cotto et al., A PHASE-II TRIAL OF FOTEMUSTINE AND CISPLATIN IN CENTRAL-NERVOUS-SYSTEM METASTASES FROM NON-SMALL-CELL LUNG-CANCER, European journal of cancer, 32A(1), 1996, pp. 69-71
Authors:
FREYER G
DESCOS L
TRILLETLENOIR V
CHANG DH
GERARD JP
Citation: G. Freyer et al., ADJUVANT CHEMOTHERAPY IN CANCER OF THE CO LON, La Presse medicale, 25(27), 1996, pp. 1241-1246
Authors:
TRILLETLENOIR V
SOLER P
ARPIN D
BOHAS C
RIOU R
COURTFORTUNE I
ECOCHARD D
PEROL M
CORDIER JF
Citation: V. Trilletlenoir et al., THE LIMITS OF CHEMOTHERAPY DOSE INTENSIFICATION USING GRANULOCYTE-COLONY-STIMULATING FACTOR ALONE IN EXTENSIVE SMALL-CELL LUNG-CANCER, Lung cancer, 14(2-3), 1996, pp. 331-341
Authors:
HULEWICZ G
GOLFIER F
CHATTE G
VITREY D
MARTEL I
RAUDRANT D
TRILLETLENOIR V
Citation: G. Hulewicz et al., PURE EMBRYONAL CARCINOMA OF THE OVARY - C ASE-REPORT AND REVIEW OF THE LITERATURE, Bulletin du cancer, 83(9), 1996, pp. 718-724
Authors:
THIEBLEMONT C
FENDLER JP
TRILLETLENOIR V
PETRIS C
CHAUVIN F
BRUNATMENTIGNY M
DEVAUX Y
DEVONEC M
GERARD JP
PERRIN P
Citation: C. Thieblemont et al., PROGNOSTIC FACTORS FOR THE SURVIVAL IN IN FILTRATING BLADDER UROTHELIAL TUMOR - RETROSPECTIVE STUDY OF 158 PATIENTS TREATED BY RADICAL CYSTECTOMY, Bulletin du cancer, 83(2), 1996, pp. 139-146
Authors:
FALCHERO L
COIFFIER B
GUIBERT B
SOUQUET PJ
PINET SI
TRILLETLENOIR V
Citation: L. Falchero et al., MALIGNANT PLEURAL MESOTHELIOMA FOLLOWING RADIOTHERAPY FOR HODGKINS-DISEASE, Bulletin du cancer, 83(11), 1996, pp. 964-968
Authors:
TRILLETLENOIR V
GREEN JA
MANEGOLD C
VONPAWEL J
GATZEMEIER U
LEBEAU B
DEPIERRE A
JOHNSON P
DECOSTER G
MATCHAM J
EWEN C
Citation: V. Trilletlenoir et al., RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP, European journal of cancer, 31A(12), 1995, pp. 2115-2116
Authors:
NICOLAS JF
BERTHIER O
TRILLETLENOIR V
CLAUDY A
REVILLARD JP
Citation: Jf. Nicolas et al., THE FUTURE OF MELANOMA STAGE-I - IMMUNOLO GY AND IMMUNOTHERAPY OF MELANOMA, Annales de dermatologie et de venereologie, 122(5), 1995, pp. 324-335
Authors:
COTTO C
QUOIX E
THOMAS F
HENANE S
TRILLETLENOIR V
Citation: C. Cotto et al., PHASE-I STUDY OF THE SOMATOSTATIN ANALOG SOMATULINE IN REFRACTORY SMALL-CELL LUNG-CARCINOMA, Annals of oncology, 5(3), 1994, pp. 290-291
Authors:
GERARD JP
TRILLETLENOIR V
THALABARD JC
Citation: Jp. Gerard et al., PRINCIPLES OF ADJUVANT TREATMENT IN GASTR OINTESTINAL-TRACT ONCOLOGY, Gastroenterologie clinique et biologique, 18(8-9), 1994, pp. 710-713
Authors:
WAGNER JP
MAHE MA
ROMESTAING P
ROCHER FP
BERGER C
TRILLETLENOIR V
GERARD JP
Citation: Jp. Wagner et al., RADIATION-THERAPY IN THE CONSERVATIVE TREATMENT OF CARCINOMA OF THE ANAL-CANAL, International journal of radiation oncology, biology, physics, 29(1), 1994, pp. 17-23
Authors:
TRILLETLENOIR V
ARPIN D
BRUNE J
Citation: V. Trilletlenoir et al., OPTIMAL DELIVERY OF DOSE IN CANCER-CHEMOTHERAPY WITH THE SUPPORT OF HEMATOPOIETIC GROWTH-FACTORS, European journal of cancer, 29A, 1993, pp. 14-16
Authors:
TRILLETLENOIR V
ARPIN D
MERCATELLO A
OSKHAM R
PALMER PA
SOUQUET PJ
CHAMPEL F
BOYER J
CORDIER JF
FRANKS CR
MOSKOVTCHENKO JF
BRUNE J
PHILIP T
Citation: V. Trilletlenoir et al., COMBINATION IL-2 AND CISPLATINUM - A PROMISING TREATMENT FOR BRONCHIOLOALVEOLAR CARCINOMA, European journal of cancer, 29A(13), 1993, pp. 1917-1918
Authors:
CHAUVIN F
SOUQUET PJ
TRILLETLENOIR V
COURTFORTUNE I
PEROL M
ECOCHARD D
REBATTU P
LAENNEC E
BERNARD JP
Citation: F. Chauvin et al., THE CLINICAL AND ECONOMIC-EVALUATION OF T HE INITIAL ASSESSMENT IN SMALL-CELL LUNG-CANCER, Revue des maladies respiratoires, 10(5), 1993, pp. 445-451
Authors:
TRILLETLENOIR V
MORNEX F
CHAUVIN F
FOURNEL P
VOLOCH A
PEROL M
LAENNEC E
PIPERNO D
BOYER J
ARDIET JM
CARRIE C
MONTBARBON X
MARQUIS I
ROMESTAING P
MERE P
TALABARD JN
CHASSARD JL
GERARD JP
SCHMITT T
GUERIN JC
Citation: V. Trilletlenoir et al., LIMITED DISEASE SMALL-CELL LUNG-CANCER - ALTERNATING COMBINATION OF DOXORUBICIN, ETOPOSIDE, IFOSFAMIDE AND HYPERFRACTIONATED RADIOTHERAPY -FINAL RESULTS OF A MULTICENTRIC PILOT-STUDY FROM THE GROUPE-LYONNAIS-ONCOLOGIE-THORACIQUE (GLOT), Lung cancer, 10(1-2), 1993, pp. 35-45
Authors:
TRILLETLENOIR V
BRUNE J
Citation: V. Trilletlenoir et J. Brune, TREATMENT OF EPITHELIAL THYMOMAS, Bulletin du cancer, 80(12), 1993, pp. 1043-1050
Authors:
ARPIN D
TRILLETLENOIR V
LASSET C
SOUQUET PJ
RIOU R
YOANIDIS I
GUIDOLLET J
CORDIER JF
BRUNE J
Citation: D. Arpin et al., INTEREST OF C-REACTIVE PROTEIN ASSAY IN S MALL-CELL LUNG-CANCER, Bulletin du cancer, 80(12), 1993, pp. 1063-1068